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The oxytocin receptor (OTR) is differentially expressed in the
CNS. Because there are multiple mechanisms by which the
OTR can be transcriptionally induced, we hypothesized that
differences in OTR expression may be explained by activation
of distinct signal transduction pathways and may be critical for
the control of anxiety and sex behaviors. To determine the
regulation and functional significance of this expression, we
infused female rats with modifiers of protein kinases before
assaying for behavior and oxytocin receptor binding. In the
ventromedial nucleus of the hypothalamus (VMH), estrogen-
dependent induction of oxytocin receptors required protein
kinase C activation, and oxytocin infused here promoted female
sex behavior but had no effect on anxiety. In contrast, dopa-
mine controlled tonic oxytocin receptor expression in the cen-
tral nucleus of the amygdala (cAmyg) through activation of
protein kinase A, and oxytocin infused here was anxiolytic but
had no effect on female sex behavior. Therefore, we have
identified brain region-specific regulation of the OTR in the
VMH and cAmyg. Distinct signal transduction pathways regu-
lating receptor expression and binding in each brain region may
mediate in part the ability of oxytocin to exert these differential
behavioral effects.
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The neuropeptide oxytocin (OT) is synthesized in neurons of the
supraoptic and paraventricular (PVN) nuclei of the hypothala-
mus, which project to the posterior pituitary and release oxytocin
into the bloodstream. This peripherally acting oxytocin is critical
for the processes of lactation and parturition. Oxytocin neurons
of the PVN also send projections to many regions within the
brain, including the hippocampus, amygdala, and hypothalamus,
in which oxytocin acts as a neurotransmitter involved in affiliative
behaviors (Insel, 1992). Oxytocin receptors (OTRs) are found in
many brain regions, including the central nucleus of the amygdala
(cAmyg) and the ventromedial nucleus of the hypothalamus
(VMH) in which they are heterologously expressed (Bale et al.,
1995a,b). These two brain regions are critical components of
neural circuits regulating distinct behavioral responses. The
VMH is an important mediator of female sex behavior (Pfaff et
al., 1994), whereas the cAmyg is a portion of the limbic system
that coordinates fear and anxiety responses (Davis, 1997;
Roozendaal et al., 1997; LeDoux, 1998). The exhibition of rat
female sex behavior requires estrogen action in the brain, includ-
ing the induction of OTRs in the VMH (McCarthy et al., 1994;
Bale and Dorsa, 1995a,b; Bale et al., 1995a,b). In contrast, OTR
levels in the cAmyg are unaffected by estradiol (Bale and Dorsa,
1995a), despite dense collections of estrogen-concentrating neu-
rons (Pfaff and Keiner, 1973).
In vitro, OTR expression is increased by activation of protein
kinase A (PKA) or protein kinase C (PKC) (Bale and Dorsa,
1998). Previously, we isolated and sequenced 4.5 kb of an up-
stream sequence of a rat genomic OTR clone from a rat testis
library and identified crucial putative response elements, includ-
ing a cAMP response element and several activator protein-1
(AP-1) sites (Bale and Dorsa, 1997). Because there are multiple
mechanisms by which the OTR can be induced transcriptionally,
we hypothesized that differences in OTR expression between the
VMH and cAmyg may be explained by activation of distinct
signal transduction pathways in these brain regions, and these
may be critical for the control of anxiety and sex behaviors.
MATERIALS AND METHODS
Animals. Sprague Dawley female rats were obtained from Charles River
(Kingston, NY) and housed under reversed light /dark cycle conditions
(lights out at 10:00 A.M.) in the animal facility of the University of
Maryland, Baltimore. All animals were ovariectomized under anesthesia
[75 mg of ketamine 1 2.5 mg of acepromazine/kg body weight (BW)] and
allowed at least 1 week to recover before the experiment. All procedures
were in accordance with the guidelines of the University of Maryland
Institutional Animal Care and Use Committee.
Acute intracerebral infusions for oxytocin receptor binding. Animals were
anesthetized (75 mg of ketamine 1 2.5 mg of acepromazine/kg BW) and
placed into a stereotaxic apparatus for site-specific infusions using a 1 ml
Hamilton syringe with attached needle. Stereotaxic coordinates for in-
fusion into the amygdala were 2.8 mm caudal to bregma, 3.75 mm lateral
to the midline, and 8.00 mm below the surface of the brain. Coordinates
for injections into the VMH were the same, except 0.75 mm lateral to the
midline. These coordinates were based on Figure 29 of the Paxinos and
Watson (1986) rat brain atlas. Bilateral infusions (1 ml per side) consisted
of phorbol ester (200 nM; Sigma, St. Louis, MO), forskolin (10 mM;
Sigma), H89 (200 mM; Calbiochem, La Jolla CA), bisindolylmalemide I
(BIM, 200 mM; Calbiochem), or the dopamine D1 receptor antagonist
R(1)-SCH-23390 hydrochloride (10 mg; Research Biochemicals, Natick,
MA). Infusions were ;1 min in duration, and the injection cannula was
left in place for an additional 30 sec before removal. At completion of the
infusion, the incision was closed with surgical staples; the animal was
treated with antibiotics and an analgesic and injected subcutaneously
with either 2 mg of estradiol benzoate (EB) or oil vehicle in 0.1 cc of
sesame oil before being returned to its home cage. To evaluate the
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inhibitory effect of BIM on OTR expression in the VMH, EB treatment
is necessary to induce a detectable level of OTRs in this brain region. No
EB treatment is necessary for OTR expression in the cAmyg because
endogenous levels are maximal without estrogen exposure, and therefore
ovariectomized females were left untreated.
Oxytocin receptor binding. Eight hours after infusion, animals were
anesthetized lightly with CO2 before decapitation. Brains were removed
rapidly, frozen briefly in isopentane, and stored at 280°C until section-
ing. Brains were cut on a cryostat (20 mm thick), and sections were
mounted onto subbed slides and frozen at 280°C until binding was
performed. Slides were thawed before being washed twice for 10 min in
50 mM Tris buffer, pH 7.4, at room temperature. Sections were then
incubated in buffer containing: 50 mM Tris, pH 7.4, 30 pM 125I-Ornithine
Vasotocin (OTA; DuPont NEN, Boston, MA), 10 mM MgCl2, 0.1%
BSA, and 0.05% bacitracin for 60 min at room temperature. Nonspecific
binding was defined in adjacent sections that were exposed to both
125I-OTA and 1 mM cold OT (Bachem, Torrance, CA). After the incu-
bation period, slides were washed four times for 5 min each in a 50 mM
Tris buffer containing 10 mM MgCl2 at 4°C. Slides were dipped rapidly in
deionized water and dried under cool air. Sections were then exposed to
film for 3 d before being developed by standard photographic methods.
Autoradiography data analysis. Film autoradiographs were analyzed
blind using a microcomputer-based image analysis system (MCID; Image
Research, St. Catherines, Ontario, Canada). Oxytocin receptor binding
optical density from autoradiographs was measured by subtracting non-
specific signal of adjacent sections from total signal to obtain the specific
signal for each tissue section. The area of measurement for all samples
was identical and was taken from the same region of the VMH or cAmyg
as determined by choosing matching brain sections before analysis.
Repeated intracerebral infusions for behavioral testing. Animals were
anesthetized (75 mg of ketamine 1 2.5 mg of acepromazine/kg BW),
placed into a stereotaxic apparatus, and implanted with a bilateral guide
cannula (22 gauge; Plastics One, Roanoke, VA) into either the VMH or
cAmyg using the same stereotaxic coordinates as for the acute infusions.
The guide cannula extended 7.5 mm into the brain, and the internal
dummy cannula extended an additional 0.5 mm. Animals were ovariec-
tomized at the same time as the implantation of the cannula. At the time
of infusion, awake animals were lightly restrained in a terry cloth towel,
the dummy cannula was removed, and an injection cannula attached to a
1 ml Hamilton syringe via PE-10 tubing was inserted into the guide
cannula. After infusions were performed in the same manner as de-
scribed above, the fully awake animal was returned to its home cage.
Depending on the experiment, animals were infused with either the
D1 antagonist SCH23390 (10 mg), the PKC inhibitor BIM (200 mM), or
the PKC activator phorbol ester (PMA, 200 nM) in the morning (;9:00
A.M.) and the evening (;5:30 P.M.) on 2 consecutive days and again on
the morning of the third day, for a total of five infusions. On the
afternoon of the third day (the midpoint of the dark cycle), animals were
infused with either oxytocin (1 mg) or saline vehicle 10–20 min before
behavioral testing.
Female sex behavior testing. Ovariectomized females were treated with
EB (in sesame oil vehicle, 2–5 mg/0.1 cc, s.c.) 48 and 24 hr before
behavioral testing. At the midpoint of the dark cycle on the day of the
test, animals were allowed to acclimate to a test arena before being tested
manually for lordosis responsiveness by an investigator blinded to the
particular treatment. Testing consisted of 10 trials of gently palpating the
flanks and exerting pressure on the rump to induce a lordosis response.
The degree of arching of the back and elevation of the rump was an
indicator of the amplitude of the response and was assigned qualitative
scores from zero (no lordosis) to three (maximal lordosis). Animals were
pretested, infused with either oxytocin (1 mg) or saline vehicle, and
post-tested within 10–20 min of infusion. Because animal variability
prevents absolute numbers for lordosis response, results were calculated
as the difference for each animal between pretest and post-test scores.
For this and all other behavioral tests, the experimenter scoring the
response was blinded to the experimental group. All animals were
treated and tested at the same time by the same investigators.
Open-field testing. At the midpoint of the dark phase of the cycle,
animals were placed for 5 min in the center of an open-field apparatus
made of clear Plexiglas (100 cm long, 80 cm wide, and 50 cm high); the
floor of the apparatus was divided into 30 equally sized squares ;16.5 cm
per side. The movement of the animal was monitored such that each
crossing over a line in the grid was noted. The squares around the
perimeter were considered “outside,” whereas all others were considered
“inside.” Data were expressed as the ratio of inside grid crossings to
outside grid crossings. Because this was a test of novelty-induced anxiety,
animals could not be pretested before drug treatment. Animals were
tested in the apparatus 10–20 min after an infusion of oxytocin (1 mg) or
saline. An increase in the inside crossings/outside crossings ratio is an
indicator of decreased anxiety. Animals tested for anxiety after infusion
into the cAmyg were not pretreated with EB because OTRs in this brain
region are maximal without estrogen exposure.
Elevated plus maze testing. Immediately after the open-field test, ani-
mals were placed in the center of a standard elevated plus maze (EPM)
apparatus of 50 cm height with 50-cm-long arms arranged perpendicu-
larly. Two opposite arms were open, and two were enclosed with dark-
ened Plexiglas walls. A 40 W bulb was suspended directly above the maze
to provide even illumination to all arms. The number of entries and time
spent in open and closed arms of the maze were recorded for 10 min with
a digital recorder.
Histology. At the completion of the behavioral experiments, all animals
were overdosed with Nembutal and perfused transcardially with ice-cold
saline followed by 4% paraformaldehyde. Brains were removed, post-
fixed for 1 hr, cryoprotected in 30% sucrose, and stored frozen at 280°C
until sectioned on a cryostat. Sections (50 mm thick) were collected
throughout the area of the cannula implant and stained with cresyl violet
for verification of correct placement.
Statistics. Binding data and lordosis responding were assessed for
statistical significance by ANOVA, and individual comparisons were
made by post hoc Kruskal–Wallis test. Open-field data expressed as a
ratio were assessed by the nonparametric Mann–Whitney U test.
RESULTS
Experiment I: Assessment of OTR binding by receptor
autoradiography after manipulation of PKA or PKC by
infusion into the VMH or cAmyg
Ventromedial hypothalamus
Representative autoradiographs of oxytocin binding in the VMH
after the various treatments are pictured in Figure 1. Quantifica-
tion of binding showed that infusion of the PKC inhibitor, BIM
(200 mM), significantly decreased OTR binding levels in the
VMH compared with saline vehicle-infused, ovariectomized
estradiol-replaced females (ANOVA; p , 0.01; n 5 4) (Fig. 2A).
Infusion of a phorbol ester (PMA, 200 nM) to mimic activation of
PKC induced a significant increase in OTR binding in the ab-
sence of estrogen, compared with saline vehicle-infused ovariec-
tomized controls ( p , 0.001; n 5 4–5) (Fig. 2A). Infusion into
the VMH of H89 (200 mM; n 5 3) to inhibit PKA in ovariecto-
mized estradiol-replaced females had no effect on OTR binding,
nor did infusion of forskolin (200 nM; n 5 3) to enhance PKA in
ovariectomized females (Fig. 2B)
Central nucleus of the amygdala
Representative autoradiographs of oxytocin binding in the
cAmyg after the various treatments are pictured in Figure 3.
Quantification of binding showed that infusion of H89, which
inhibits PKA activity, significantly decreased OTR binding in this
nucleus compared with vehicle-infused ovariectomized controls
(ANOVA; p , 0.01; n 5 4) (Fig. 4A). The cAmyg expresses
dopamine D1 receptors that are positively coupled to adenylate
cyclase and downstream activation of PKA. Infusion of the D1
antagonist SCH23390 significantly decreased OTR binding den-
sity in the cAmyg of ovariectomized females, compared with
vehicle-infused controls ( p , 0.01; n 5 3–4) (Fig. 4B). Infusion
of forskolin, an activator of PKA, combined with SCH23390
reversed the effects of the D1 antagonist, resulting in a return to
near basal levels of OTR binding that was significantly greater
than the SCH antagonist alone ( p , 0.05; n 5 3) (Fig. 4B).
Infusion of the PKC inhibitor, BIM (200 mM), was without effect
on OTR binding in the cAmyg of ovariectomized females (vehi-
cle, 0.295 6 0.07; BIM, 0.261 6 0.09).
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Experiment II: Assessment of site-specific behavioral
effects of oxytocin infusion
Female sex behavior
Oxytocin infused into the VMH of females primed with a low
dose of estradiol significantly increased lordosis responding (one-
way ANOVA with repeated measures post hoc Kruskal—Wallis;
p , 0.001; n 5 9) (Fig. 5A) but had no effect on lordosis when
infused into the cAmyg ( p . 0.5; n 5 8) (Fig. 5B). The VMH
oxytocin-induced increase in lordosis was blocked by previous
treatment with the PKC inhibitor, BIM ( p , 0.001) (Fig. 5A).
The ability of VMH-infused oxytocin to enhance lordosis re-
sponding was also evident in animals pretreated with the PKC
activator PMA ( p , 0.01), although there was no difference
between animals pretreated with PMA or saline vehicle when
they were given oxytocin (data not shown).
Open-field test
Oxytocin infusion into the cAmyg significantly increased open-
field activity compared with controls, almost tripling the inside
crossings/outside crossings compared with saline-infused animals
(Mann–Whitney U test; p , 0.01; n 5 9 for oxytocin-infused; n 5
6 for saline-infused) (Fig. 6A). The D1 antagonist SCH23390
blocked this effect of oxytocin ( p , 0.01; n 5 8) (Fig. 6A). In
contrast, oxytocin infusion into VMH had no effect on open-field
activity when compared with saline-infused controls (Mann—
Whitney U test; p . 0.8) (Fig. 6B). There was no difference in the
total number of crossings between any groups, indicating no
changes in general locomotor activity (VMH oxytocin infusion 5
126.2 6 49.4; saline 5 126.0 6 25.7; cAmyg oxytocin infusion 5
112.3 6 11.6; oxytocin 1 SCH23390 5 123.4 6 14.1; cAmyg
saline 5 137.7 6 19.8).
Elevated plus maze
Although infusion of oxytocin into the cAmyg appeared to in-
crease the amount of time spent on the open arm of the plus maze
and infusion of the D1 antagonist SCH23390 decreased the
amount of time spent in the open arms when compared with
oxytocin-infused controls (SCH23390 1 oxytocin 5 53.4 6 6.6
sec, compared with oxytocin 5 63.6 6 12.0 sec and vehicle 5
50.3 6 11.3 sec), these differences failed to reach statistical
significance. There were no differences in total arm entries when
comparing oxytocin and saline infusion (oxytocin 1 SCH23390 5
14.4 6 2.8; oxytocin 5 10.9 6 1.8; saline 5 11.5 6 1.8), again
indicating no changes in general locomotor activity as a result of
Figure 1. Representative autoradiographs illustrating oxytocin receptor
binding in the VMH. Animals were pretreated with estradiol (2 mg) or oil
vehicle by subcutaneous injection; infused centrally, directly into the
VMH with BIM (inhibitor of PKC) or the phorbol ester, PMA, 8 hr
before collection of the brains; and assayed for OTR binding by quanti-
tative receptor autoradiography. Treatment groups were as follows: A,
subcutaneous oil vehicle injection, saline vehicle infusion into the VMH;
B, subcutaneous estradiol injection, saline vehicle infusion into the VMH;
C, subcutaneous estradiol injection, BIM infusion into the VMH; D,
subcutaneous oil vehicle injection, PMA infusion into the VMH. Arrow
indicates region of VMH that was analyzed.
Figure 2. Quantification of OTR binding in the VMH. A, Optical
density levels of OTR binding in the VMH of ovariectomized rats treated
peripherally with estradiol (E2) or oil vehicle and centrally with inhibitors
(BIM ) or activators (PMA) of PKC. Treatment groups were Veh (subcu-
taneous oil vehicle injection, saline vehicle infusion into the VMH; n 5
4), E2 [subcutaneous estradiol (2 mg) injection, saline vehicle infusion into
the VMH; n 5 7], E2 1 BIM [subcutaneous estradiol injection, BIM (200
mM) infusion into the VMH; n 5 4], or PMA [subcutaneous oil vehicle
injection, PMA (200 nM) infusion into the VMH; n 5 5]. Brains were
collected 8 hr after drug infusion and steroid treatment. Data were
analyzed by one-way ANOVA and indicate a significant effect of treat-
ment [F(3,16) 5 12.01; p , 0.001]; post hoc analysis indicates that a is
significantly different from b ( p , 0.01) and c ( p , 0.001). B, When
compared with the same Veh- and E2-treated groups as above, infusion of
forskolin (Forsk) (200 nM; n 5 3), an activator of PKA, or H89 (E2 1
H89) (200 mM; n 5 3), an inhibitor of PKA, into the VMH of ovariec-
tomized females was without effect on OTR binding in the VMH. All
values are 6 SEM.
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oxytocin infusion. Oxytocin infusion into the VMH had no effect
on EPM activity when compared with saline-infused controls
(data not shown).
The location of the infusion sites based on cresyl violet-stained
sections resulted in the exclusion of one animal for cAmyg be-
cause of improper cannula placement.
DISCUSSION
We report here the regionally specific regulation of OTR binding
and its significance in the control of anxiety and sex behaviors. In
the female rat VMH, OTR binding is reduced by up to 200-fold
after ovariectomy and can be restored fully by replacement of
estradiol (Johnson et al., 1989). A component of the estradiol-
induced increase in OTRs involves increased levels of mRNA
(Bale and Dorsa, 1995a,b), but whether this involves a genomic
effect of estradiol is unknown. The mechanisms by which steroids
can alter cellular functions have been expanded recently to in-
clude interactions with cytoplasmic signal transduction pathways
(Zhou et al., 1996; Toran-Allerand et al., 1999). Our data indicate
that estradiol increases oxytocin receptor binding in the VMH
via a PKC-dependent mechanism. Inhibition of PKC in the VMH
blocked the ability of estradiol to increase OTR binding, whereas
activation of PKC significantly increased OTR binding in the
absence of estrogen. Therefore, the estradiol-induced increase in
OTR binding in the VMH functions through activation of PKC
and not through genomic actions of estrogen receptor directly at
the OTR promoter.
In contrast to results in the VMH, OTR binding in the cAmyg
is not regulated by estradiol (Bale et al., 1995a,b), and here we
report that it is tonically maintained via a PKA-dependent mech-
anism involving the dopamine D1 receptor. This is the first
evidence to suggest an interaction between the OTR and dopa-
mine systems in the cAmyg. Inhibition of PKA in the cAmyg by
H89 significantly decreased OTR binding when compared with
controls. OTR binding was also reduced by antagonism of the
dopamine D1 receptor by SCH23390. Tonic dopamine input into
the cAmyg likely activates PKA through D1 receptors. The main-
tenance of OTR binding in the cAmyg appears specific to PKA
Figure 3. Representative autoradiographs illustrating OTR binding in the cAmyg. Animals were infused directly into the cAmyg, and brains were
collected 8 hr later and assayed for OTR binding by quantitative receptor autoradiography. Treatments were as follows: A, saline vehicle infusion into
the cAmyg; B, H89 (PKA inhibitor) infusion into the cAmyg; C, SCH23390 (dopamine D1 receptor antagonist) infusion into the cAmyg; or D,
SCH23390 1 forskolin infusion into the cAmyg. Arrow indicates region of cAmyg that was analyzed.
Figure 4. Quantification of OTR binding in the cAmyg. Ovariectomized
rats were treated as follows: A, Veh 1 (saline vehicle for H89 infusion into
the cAmyg; n 5 7), and H89 (H89 infusion into cAmyg; n 5 5); B, Veh 2
(saline vehicle for SCH23390 infusion into the cAmyg; n 5 2); SCH
(SCH23390 infusion into the cAmyg; n 5 3), or SCH 1 Forsk (SCH23390
1 forskolin infusion into the cAmyg; n 5 3). Brains were collected 8 hr
after drug infusion. There was a significant effect of H89 infusion
[ANOVA; F(1,10) 5 13.96] and SCH23390 infusion [F(3,7) 5 10.62; p ,
0.01] when each was compared with its own controls. Post hoc analysis,
**p , 0.01. All values are 6 SEM. Previous treatment with estradiol was
found to have no influence on the effectiveness of H89 treatment (data not
shown).
Figure 5. Effects of oxytocin infusion into the VMH and cAmyg on
female sex behavior. Animals were primed with low doses of estradiol for
2 d and then pretested for lordosis responding before infusion of oxytocin
(OT; 1 mg) or saline (Sal ) into the VMH or cAmyg. Post-testing was
performed 10–20 min after infusion. Data are presented as the increase
in lordosis amplitude between the pretest and post-test. A, For animals
with indwelling cannulas in the VMH, oxytocin infusion significantly
increased lordosis responding compared with animals either infused with
saline or pretreated for 2 d with the PKC inhibitor, BIM. ANOVA with
post hoc Kruskal—Wallis; **p , 0.001; n 5 9 for all groups. These results
show that oxytocin infusion into the VMH increases lordosis behavior
and this behavior is blocked by pretreatment with BIM. B, For animals
with indwelling cannulas in the cAmyg, there was no difference in lordosis
responding between those infused with oxytocin (n 5 5) versus saline
[n 5 4; F(1,14) 5 0.25; p . 0.5]. All values are 6 SEM.
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because activation or inhibition of PKC had no effect at this brain
site.
Oxytocin has been referred to as an “affiliative” hormone
because of its intimate involvement in the regulation of behaviors
involving attachment or close interaction between animals, in-
cluding anxiety and sex behavior (Insel and Shapiro, 1992; Mc-
Carthy and Altemus, 1997). Consistent with previous reports
(Schumacher et al., 1990; Schulze and Gorzalka, 1991), we found
that infusion of oxytocin into the VMH increased female sex
behavior as measured by lordosis responding. However, when
PKC was inhibited, the enhancing effect of oxytocin on lordosis
was blocked. The results of our binding studies suggest that the
effect of PKC inhibition on lordosis may be caused by the conse-
quent reduction of OTR expression in the VMH, although we
cannot rule out possible interactions with other components nec-
essary for a lordotic response. We attempted to increase OTR
levels by activation of PKC with a phorbol ester, with the predic-
tion that oxytocin effects on lordosis would be enhanced. Al-
though we continued to observe a significant increase in lordosis
amplitude and frequency after oxytocin infusion, there was no
statistical difference in oxytocin effectiveness between females
pretreated with a phorbol ester versus saline. This is likely attrib-
utable to a maximal level of OTR expression after the estrogen
treatment. Estrogen has pleiotropic effects on lordosis responding
that are not limited to an effect via increased OTR binding (Pfaff
et al., 1994). Nonetheless, our data are the first to demonstrate
that oxytocin stimulation of lordosis behavior involves the acti-
vation of PKC to increase OTR transcription. Previous studies
have shown that PKC activation in the VMH can increase female
sex behavior (Kow and Pfaff, 1998) but have not implicated a
specific neurotransmitter. Estradiol may directly activate the
phosphatidylinositol second messenger pathway leading to PKC
activation (Mobbs et al., 1989) or act indirectly by inducing the
expression of PKC isoforms or fos and jun complexes that can
then interact with PKC to stimulate transcription at AP-1 sites
(Gaub et al., 1990) as are found in the OTR promoter (Bale and
Dorsa, 1998). It cannot be overlooked that inhibition of PKC may
also affect other processes within the VMH that may alter lor-
dosis behavior.
In contrast to the VMH, the cAmyg is a component of the
limbic system and is involved in “emotional” responses, includ-
ing fear and defensive behaviors (LeDoux, 1998). Oxytocin has
been reported to have anxiolytic (McCarthy et al., 1996) and
antidepressant (Arletti and Bertolini, 1987) actions, as well as
facilitating pair-bonding (Williams et al., 1994; Insel and Hu-
lihan, 1995) and mother–infant interactions (Pedersen and
Prange, 1979; Fahrbach et al., 1984). Any or all of these may
involve oxytocin action on the cAmyg. These behavioral re-
sponses are modulated by estradiol, but are not dependent on
estradiol, as is the case for VMH regulation of female sex
behavior. The exact CNS site(s) at which oxytocin acts to exert
an anxiolytic effect is unknown. The cAmyg is one of the
nuclei of the amygdala that receives convergent information
from several other amygdaloid regions. It has been proposed
that the afferents of this nucleus generate behavioral responses
that reflect the sum of neuronal activity produced by the
amygdala complex (Pitkanen et al., 1997). These observations
led us to speculate that adaptive selective pressure has been in
favor of a constitutive expression of OTRs in the cAmyg to
allow for rapid responses to stressful or emotional stimuli by
reducing anxiety. The cAmyg receives direct dopaminergic
innervation from the midbrain, and neurons of this nucleus
innervate the dopamine neurons of the substantia nigra (Rouil-
lard and Freeman, 1995). Conditioned stressors increase the
activity of dopamine neurons projecting to several components
of the amygdala, including the central nucleus (Coco et al.,
1992). Our findings suggest that one function of increased
dopamine release to the cAmyg is the maintenance and/or
increase of OTR expression levels. Oxytocin is also released
centrally in response to a wide variety of stressors (Samson et
al., 1985; Nishioka et al., 1998). Therefore, the oxytocin and
dopaminergic systems may act in concert to reduce anxiety in
response to social and environmental stressors. We found that
oxytocin infusion into the cAmyg increased open-field activity
almost threefold and that this effect was not present in animals
pretreated with a D1 receptor antagonist. On the basis of our
binding results, it is likely that the level of OTRs had been
sufficiently reduced by pretreatment with the dopamine antag-
onist such that the oxytocin infused into the cAmyg could no
longer exert an anxiolytic effect. Anxiety testing using the
same treatments did not reach significance in the elevated plus
maze. We believe that the open-field test is of more ethological
relevance here because female rodents must leave their burrow
and enter into an open field to mate. Oxytocin is strongly
implicated in the control of social behaviors, suggesting that
the difference in magnitude of the anxiolytic effect between the
open field and elevated plus maze may be a function of
measuring different types of anxiety and their potential social
context. In contrast to the cAmyg, oxytocin infusion into the
VMH had no effect on anxiety responses. To our knowledge,
this is the first report of a site-specific anxiolytic effect of
oxytocin.
A remaining question is the mechanism by which heteroge-
neous regulation of OTR expression is achieved in the cAmyg
and VMH. The potential for an undiscovered second OTR gene
in the cAmyg cannot be ruled out, and there is considerable
Figure 6. Effects of oxytocin infusion into the VMH and cAmyg on
activity in an open field. Animals were placed into the center of an
open-field testing apparatus within 10–20 min of infusion of oxytocin (1
mg) or saline. The ratio of inside/outside crossings is a useful overall
indicator of activity in an open field. An increase in the ratio indicates
reduced anxiety-like behavior because it demonstrates that the animals
are more willing to explore the center of the open field. A, For animals
with indwelling cannulas in the cAmyg and infused with oxytocin (n 5 9),
there was a significant increase in the ratio when compared with saline-
infused controls (n 5 6). This effect was blocked by pretreatment with the
dopamine D1 receptor antagonist, SCH23390 (n 5 8) (**p , 0.01;
ANOVA). There were no differences in overall activity between any
groups. B, For animals with indwelling cannulas in the VMH, there was
no effect of oxytocin infusion on activity in the open field.
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circumstantial evidence to support this view (Bale et al., 1995a;
Verbalis et al., 1995; Verbalis, 1999). An alternate hypothesis is
based on the presence of three large TG-dinucleotide repeats in
the OTR promoter (Bale and Dorsa, 1997). Submillimolar
levels of calcium have been shown to regulate DNA structure
at these TG-dinucleotide repeats in the other genes, causing an
alteration in structure of the promoter and brain region-
specific expression of the protein (Dobi and v Agoston, 1998).
The heterologous regulation of OTR expression in the cAmyg
and VMH may be a function of differences in availability of
response elements in the promoter caused by induction of
secondary structure.
In summary, we have identified brain region-specific regulation
of the OTR in the VMH and cAmyg and have demonstrated that
this heterologous regulation is critical for two different behavioral
effects of oxytocin. Although the estrogen-dependent OTR ex-
pression in the VMH is induced by activation of the PKC path-
way, the receptors in the cAmyg are dependent on PKA and are
tonically activated through dopamine D1 receptors in this nu-
cleus. In the cAmyg, oxytocin acts to decrease anxiety, but in the
VMH it acts to stimulate female sex behavior. A schematic
representation of these results is depicted in Figure 7. Sex recep-
tivity in the female rat is dependent on appropriate levels and
duration of exposure to estradiol, thereby temporally restricting
its expression to coincide with the event of ovulation. In contrast,
behavioral responses to anxiety-provoking stimuli such as novelty
require a continuously primed neural substrate to allow for rapid
adaptation. OTRs in the VMH and cAmyg appear to regulate
these different behaviors, respectively, and the distinct signal
transduction pathways regulating receptor expression and binding
in each brain region may mediate in part the ability of oxytocin to
exert these differential effects.
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